Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies

Keyphrases

• Alpha-1 Antitrypsin Deficiency 100%
• Lung Disease 66%
• Augmentation Therapy 66%
• Cell-based 33%
• Gene Therapy 33%
• Recombinant 33%
• Hepatocytes 33%
• Lung 33%
• Liver Disease 33%
• Therapeutic Strategies 33%
• Chronic Obstructive Pulmonary Disease 33%
• Neutrophil Elastase 33%
• Harmful Effects 33%
• Rare Cause 33%
• Polymer Formation 33%
• Effective Rate of Protection 33%
• Autophagy-related Genes 33%

Medicine and Dentistry

• Alpha 1-Antitrypsin Deficiency 100%
• Silo-Filler's Disease 66%
• Gene Therapy 33%
• Lung 33%
• Hepatocyte 33%
• Liver Disease 33%
• Chronic Obstructive Pulmonary Disease 33%
• Leukocyte Elastase 33%
• Autophagy 33%
• Stem Cell 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Alpha 1 Antitrypsin Deficiency 100%
• Lung Disease 66%
• Chronic Obstructive Lung Disease 33%
• Leukocyte Elastase 33%
• Liver Disease 33%